Discontinuation report ROPIVACAINE HYDROCHLORIDE INJECTION USP

Last updated on 2022-10-02 History
Report ID 170502
Drug Identification Number 02347822
Brand name ROPIVACAINE HYDROCHLORIDE INJECTION USP
Common or Proper name ROPIVACAINE HYDROCHLORIDE INJECTION USP
Company Name PFIZER CANADA ULC
Market Status CANCELLED POST MARKET
Active Ingredient(s) ROPIVACAINE HYDROCHLORIDE
Strength(s) 5MG
Dosage form(s) SOLUTION
Route of administration EPIDURAL BLOCK/INFILTRATION EPIDURAL BLOCK/INFILTRATION
Packaging size 10 x 30mL vial
ATC code N01BB
ATC description ANESTHETICS, LOCAL
Reason for discontinuation Business reasons
Anticipated discontinuation date
Actual discontinuation date 2022-10-01
Remaining supply date 2022-10-01
Discontinuation status Discontinued
Discontinuation decision reversal No
Information on remaining supply
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 17300 TRANS-CANADA HIGHWAY
KIRKLAND, QUEBEC
CANADA H9J 2M5
Company contact information Customer Service / service à la clientèle : 1-888-999-8750 Email / courriel: PharmaCustomerServiceDept@pfizer.com

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v3 2022-10-02 English Compare
v2 2022-09-30 French Compare
v1 2022-09-30 English Compare

Showing 1 to 3 of 3